Market Access Archives

Blog

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

Editor’s Note: Jiwon Oh provided research support for this article. She is a Certara Market…

Danielle Pillsbury2025 年 5 月 23 日

White Paper

ILAP 2.0 核心要点全解析

This white paper share’s key insights on the relaunch of MHRA’s Innovative Licensing and Access…

Certara2025 年 5 月 19 日

Brochure

确立并宣传医疗保健产品的价值

Simona Colucci2024 年 10 月 9 日

Case Study

联合临床评估（JCA）及其对基因疗法评估的潜在影响

In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…

Danielle Pillsbury2024 年 6 月 17 日

Case Study

利用价值传播技术和综合工作流程加快药品上市速度

With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical…

Jim Gallagher2023 年 10 月 2 日

Case Study

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular,…

Jim Gallagher2023 年 10 月 2 日

Case Study

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…

Danielle Pillsbury2023 年 4 月 17 日

Case Study

运用真实世界证据指导治疗指南制定

Real-World Evidence (RWE) has become increasingly valuable in informing the development of treatment guidelines for…

Danielle Pillsbury2023 年 4 月 5 日

Case Study

Using Real Word Evidence to Enhance Drug Development

Real-world evidence (RWE) has emerged as an increasingly important tool in the drug development process,1…

Danielle Pillsbury2023 年 4 月 5 日

Case Study

基于主体的模型可预测大流行期间单克隆抗体治疗、预防和疫苗对病毒传播的影响

Agent-based models focus on the heterogeneous behavior of individual agents and their interactions with one…

Danielle Pillsbury2023 年 3 月 2 日

市场准入

‘Most Favored Nation’ Policy Could Have Profound Impact on Global Drug Pricing if Fully Implemented

ILAP 2.0 核心要点全解析

确立并宣传医疗保健产品的价值

联合临床评估（JCA）及其对基因疗法评估的潜在影响

利用价值传播技术和综合工作流程加快药品上市速度

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

运用真实世界证据指导治疗指南制定

Using Real Word Evidence to Enhance Drug Development

基于主体的模型可预测大流行期间单克隆抗体治疗、预防和疫苗对病毒传播的影响

订阅时事通讯

快捷链接

解决方案

联系我们